Tech Company Financing Transactions

Sideris Pharmaceuticals Funding Round

On 10/23/2013, Sideris Pharmaceuticals raised $32 million in Series A financing from MPM Capital, Hatteras Venture Partners and Novartis BioVenture Fund.

Transaction Overview

Company Information

Company Status

Private & Independent

Industry

Biopharmaceutical

Mailing Address

200 Clarendon St. 54th Floor
Boston, MA 02116
USA

Phone

(617) 425-9232

Website

www.siderispharma.com

Email Address

Not Recorded

Overview

Sideris Pharmaceuticals is an independent biopharmaceutical company focused on the development of treatments for diseases of iron overload, including conditions involving maintenance transfusion therapy.

Profile

Social Media

Company News

Facebook

YouTube

Management Team

Title

Name

Email & Social

Chief Executive Officer

Gregory Berk

        

Browse more venture capital transactions:

Prev: 10/23/2013: Axcella Health venture capital transaction
Next: 10/23/2013: Zen Planner venture capital transaction

Share this article

Where The Data Comes From

We do our best to document tech company VC transactions. All VC database entries reported here are derived from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary